A new model to estimate prognosis in patients with hepatocellular carcinoma after Yttrium-90 radioembolization.

A new model to estimate prognosis in patients with hepatocellular carcinoma after Yttrium-90 radioembolization.

AIMS: The current prognostic model to estimate the survival in hepatocellular carcinoma (HCC) patients treated with transarterial hepatic selective internal radiotherapy (SIRT) is not fully characterized. The aim of this study was to establish a new scoring model including assessment of both tumor r...

Full description

Bibliographic Details
Main Authors:	Zhihong Weng, Judith Ertle, Shaoping Zheng, Thomas Lauenstein, Stefan Mueller, Andreas Bockisch, Guido Gerken, Dongliang Yang, Joerg F Schlaak
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3867327?pdf=render

Similar Items

Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma
by: Lee VHF, et al.
Published: (2015-11-01)

History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma
by: Aman Saini, et al.
Published: (2019-01-01)

Experience of Yttrium-90 radioembolization in patients with hepatocellular carcinoma
by: B. Zapote Hernández, et al.
Published: (2020-09-01)

Tuning Your RADIOembolization| Imaging-guidance of Yttrium-90 Radioembolization
by: Gordon, Andrew Christian
Published: (2016)

Side Effects of Yttrium-90 Radioembolization
by: Ahsun eRiaz, et al.
Published: (2014-07-01)

Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma
by: Alexander Villalobos, et al.
Published: (2021-01-01)

Yttrium-90 radioembolization of unresectable hepatocellular carcinoma – a single center experience
by: Meyer C, et al.
Published: (2017-09-01)

Yttrium-90 radioembolization in patients with hepatocellular carcinoma who have previously received sorafenib
by: Nitesh eRana, et al.
Published: (2013-12-01)

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients
by: Teyateeti A, et al.
Published: (2020-09-01)

Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer
by: Raval eMihir, et al.
Published: (2014-07-01)

Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts?
by: Jens M Theysohn, et al.
Published: (2015-01-01)

Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer
by: Alexander C. Bunck, et al.
Published: (2017-07-01)

Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases
by: Ron C. Gaba, et al.
Published: (2012-08-01)

Celiac Artery Stenting to Facilitate Hepatic Yttrium-90 Radioembolization Therapy
by: Murthy R. Chamarthy, et al.
Published: (2012-01-01)

A systematic review on the safety and effectiveness of yttrium-90 radioembolization for hepatocellular carcinoma with portal vein tumor thrombosis
by: Zhongzhi Jia, et al.
Published: (2016-01-01)

Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments
by: Cappelli A, et al.
Published: (2014-11-01)

Prediction of hepatocellular carcinoma response to 90Yttrium radioembolization using volumetric ADC histogram quantification: preliminary results
by: Sonja Gordic, et al.
Published: (2019-05-01)

Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases: A Single Institution Experience
by: Gary W. Nace, et al.
Published: (2011-01-01)

Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres
by: Hoda Rezaei Roshan, et al.
Published: (2015-01-01)

Effect of Yttrium-90 transarterial radioembolization in patients with non-surgical hepatocellular carcinoma: A systematic review and meta-analysis.
by: Simon Lemieux, et al.
Published: (2021-01-01)

Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma
by: Mostafa Mohamed, MD, et al.
Published: (2016-01-01)

Prognostic Factors for Overall Survival in Advanced Intrahepatic Cholangiocarcinoma Treated with Yttrium-90 Radioembolization
by: Michael Köhler, et al.
Published: (2019-12-01)

Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology
by: Sen Lu, et al.
Published: (2021-02-01)

Yttrium-90 radioembolization for the treatment of unresectable liver cancer: Results of a single center
by: Özhan Özgür, et al.
Published: (2014-03-01)

Case Report of Cirrhosis following Yttrium-90 Radioembolization for Pancreatic Neuroendocrine Liver Metastases
by: Jonathan M. Loree, et al.
Published: (2016-01-01)

Cholecystitis after yttrium-90 resin microsphere radioembolization treatment: Clinical and pathologic findings
by: Sagun Parakh, et al.
Published: (2016-07-01)

Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma: a systematic review and meta-analysis
by: Yi Yang, et al.
Published: (2018-09-01)

Lobar Hepatocellular Carcinoma with Ipsilateral Portal Vein Tumor Thrombosis Treated with Yttrium-90 Glass Microsphere Radioembolization: Preliminary Results
by: M. Pracht, et al.
Published: (2013-01-01)

Autoradiography and biopsy measurements of a resected hepatocellular carcinoma treated with 90 yttrium radioembolization demonstrate large absorbed dose heterogeneities
by: Jens Hemmingsson, MS, et al.
Published: (2018-07-01)

Comparison of Safety and Efficacy of Yttrium-90 Radioembolization for Nonalcoholic Fatty Liver Disease-Associated and Hepatitis B Virus-Associated Hepatocellular Carcinoma
by: Lei Liang, et al.
Published: (2020-03-01)

A pooled analysis of transarterial radioembolization with yttrium-90 microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma
by: Zhen Y, et al.
Published: (2019-06-01)

Trans-arterial 90yttrium radioembolization for patients with unresectable tumors originating from the biliary tree
by: Joost W. Wijlemans, et al.
Published: (2011-07-01)

Prospective longitudinal quality of life and survival outcomes in patients with advanced infiltrative hepatocellular carcinoma and portal vein thrombosis treated with Yttrium-90 radioembolization
by: Minzhi Xing, et al.
Published: (2018-01-01)

Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival.
by: Francesco Somma, et al.
Published: (2019-01-01)

A Woman with Black Beads in Her Stomach: Severe Gastric Ulceration Caused by Yttrium-90 Radioembolization
by: Indu S. Voruganti, et al.
Published: (2018-01-01)

Prediction of survival according to kinetic changes of cytokines and hepatitis status following radioembolization with yttrium-90 microspheres
by: Chien-An Liu, et al.
Published: (2021-04-01)

Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis
by: Antonio Facciorusso, et al.
Published: (2020-04-01)

Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization.
by: Mattijs Elschot, et al.
Published: (2013-01-01)

Yttrium-90 Radioembolization of Metastatic Adrenocortical Carcinoma to the Liver following Systemic Chemotherapy and Surgical Resection of the Primary Lesion
by: Nicholas Pigg, et al.
Published: (2020-02-01)

Safety and Efficacy of Combined Yttrium 90 Resin Radioembolization with Aflibercept and FOLFIRI in a Patient with Metastatic Colorectal Cancer
by: Andre De Souza, et al.
Published: (2015-01-01)